Skip to main content
Karen Carlson, MD, Oncology, Milwaukee, WI, Froedtert and the Medical College of Wisconsin Froedtert Hospital

KarenBarkerCarlsonMDMD, PhD

Oncology Milwaukee, WI

Hematologic Oncology

Associate Professor

Dr. Carlson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Carlson's full profile

Already have an account?

  • Office

    9200 W Wisconsin Ave
    Division Of Neoplastic Diseases
    Milwaukee, WI 53226
    Phone+1 414-805-6800
    Fax+1 414-805-6805
  • Is this information wrong?

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2008 - 2011
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2006 - 2008
  • University of Wisconsin School of Medicine & Public Health
    University of Wisconsin School of Medicine & Public HealthClass of 2004

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2013 - 2025
  • NY State Medical License
    NY State Medical License 2008 - 2014
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • A Multisite Phase Ib Study of Pevonedistat, Azacitidine and Venetoclax (PAVE) for the Treatment of Subjects with Acute Myelogenous Leukemia (AML)
    Karen-Sue B. Carlson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Epigenomic Signatures in Myelodysplastic Syndrome Patients As Predictors of Donor Compatibility and Transplant Outcome
    Karen-Sue B. Carlson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Lintuzumab Ac-225 in Combination with CLAG-M Chemotherapy in Relapsed/Refractory AML: Interim Results of a Phase I Study
    Karen Carlson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Reducing Venous Thrombosis with Antithrombin Supplementation in Patients Undergoing Treatment for ALL with Asparaginase Based Regimens 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Hospital Affiliations